Corrigendum to “ApoptomiRs expression modulated by BCR–ABL is linked to CML progression and imatinib resistance” [Blood Cells Mol. Dis. 53 (1–2) (June–August 2014) 47–55]
Titel:
Corrigendum to “ApoptomiRs expression modulated by BCR–ABL is linked to CML progression and imatinib resistance” [Blood Cells Mol. Dis. 53 (1–2) (June–August 2014) 47–55]
Auteur:
Ferreira, A.F. Moura, L.G. Tojal, I. Ambrósio, L. Pinto-Simões, B. Hamerschlak, N. Calin, G.A. Ivan, C. Covas, D.T. Kashima, S. Castro, F.A.